Bottom line
AHSZX vs RYHIX: the short answer
AHSZX (Alger Health Sciences Fund) and RYHIX (Health Care Fund) are quite different portfolios: only about 37% of their top holdings (by weight) are shared.
But RYHIX is far broader, holding 135 positions to 55 for AHSZX, so beyond the top names it adds exposure AHSZX doesn't have.
AHSZX is cheaper at 0.76% vs 1.38% — a difference of $62 a year per $10,000 invested.
Over five years, RYHIX returned +5.1% a year vs −1.6% for AHSZX.
Updated Nov 19, 2026
AHSZX vs RYHIX side by side
| AHSZX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Alger | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.76% | 1.38% |
| Annual cost per $10k | $76 | $138 |
| 10-yr cost on $10k (prospectus) | $1,004 | $1,709 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +10.6% | +14.4% |
| 5-yr return (annualized) | −1.6% | +5.1% |
| 10-yr return (annualized) | +7.8% | +7.9% |
| Best quarter | +24.6% | +18.7% |
| Worst quarter | −18.6% | −14.4% |
| Net assets (fund) | $75.4M | $19.4M |
| Number of holdings | 55 | 135 |
| Portfolio turnover | 289% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | AHSZX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +10.6% | +14.4% | −3.9% |
| 2024 | +1.6% | +0.6% | +1.0% |
| 2023 | −3.9% | +5.8% | −9.7% |
| 2022 | −16.7% | −11.6% | −5.1% |
| 2021 | +2.8% | +19.2% | −16.5% |
| 2020 | +31.5% | +18.9% | +12.5% |
| 2019 | +22.4% | +22.8% | −0.4% |
| 2018 | +6.2% | +1.6% | +4.6% |
| 2017 | +37.7% | +23.5% | +14.3% |
| 2016 | −2.9% | −9.4% | +6.5% |
Source: Fund prospectus bar charts
Holdings overlap
9 of AHSZX's top 25 holdings also appear in RYHIX's top 25.
| Holding | AHSZX | RYHIX |
|---|---|---|
| Merck & Company Inc | 4.18% | 2.04% |
| Johnson & Johnson | 4.06% | 2.88% |
| Thermo Fisher Scientific Inc | 4.00% | 1.61% |
| Cvs Health Corp | 3.67% | 1.31% |
| Unitedhealth Group Inc | 3.61% | 2.22% |
| Eli Lilly & Company | 3.29% | 3.63% |
| Abbott Laboratories | 2.93% | 1.42% |
| Novo Nordisk A/s | 2.24% | 0.83% |
| Vertex Pharmaceuticals Inc | 1.80% | 1.34% |
Source: SEC Form N-PORT
AHSZX top 10
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Merck & Company Inc — 4.18%
- Welltower Inc — 4.12%
- Johnson & Johnson — 4.06%
- Thermo Fisher Scientific Inc — 4.00%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Unitedhealth Group Inc — 3.61%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between AHSZX and RYHIX?
Which is cheaper, AHSZX or RYHIX?
Should I own both AHSZX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.